This is sponsored content issued on behalf of Psyched Wellness, please see full disclaimer here.
More From The Market Online
Theralase’s bladder cancer drug under investigation in clinical study
Pharma stock Theralase Technologies (TSXV:TLT) announces a significant update on its ongoing bladder cancer clinical study.
- Jonathon Brown
- 3 mins
- 07 October 2024 10:21 (EDT)
How BioVaxys’ DPX platform creates anti-cancer immune response
Discover BioVaxys' innovative DPX platform, a cutting-edge lipid-based delivery system transforming immunotherapy.
- Research
- 1 min
- 08 October 2024 07:00 (EDT)
Three high-quality micro-cap stocks for your coffee-can portfolio
High-quality micro-cap stocks are best buried in coffee cans in your back yard and forgotten for a very long time.
- Trevor Abes
- 5 mins
- 04 October 2024 06:30 (EDT)
One of the best Venture pharma stocks has grown even stronger
Voyageur Pharmaceuticals (TSXV:VM) has made significant strides with the approval of five new formulations by Health Canada.
- Jonathon Brown
- 4 mins
- 03 October 2024 09:18 (EDT)